Orthofix (OFIX) stock price, revenue, and financials
Orthofix market cap is $869.6 m, and annual revenue was $459.96 m in FY 2019
$45.68
$869.6 M
OFIX Mkt cap, 22-Feb-2021$111 M
Orthofix Revenue Q3, 2020Orthofix Gross profit (Q3, 2020)84.7 M
Orthofix Gross profit margin (Q3, 2020), %76.4%
Orthofix Net income (Q3, 2020)4.7 M
Orthofix EBIT (Q3, 2020)4.2 M
Orthofix Cash, 30-Sept-202079.8 M
Orthofix EV812.8 M
Orthofix Revenue
Orthofix revenue was $459.96 m in FY, 2019 which is a 1.5% year over year increase from the previous period.
Orthofix Revenue Breakdown
Orthofix revenue breakdown by business segment: 42.9% from Bone Growth Therapies, 20.6% from Spinal Implants, 14.2% from Biologics and 22.3% from Orthofix Extremities
Orthofix revenue breakdown by geographic segment: 78.7% from United States and 21.3% from Other
Orthofix Income Statement
Annual
| USD | FY, 2017 | FY, 2018 | FY, 2019 |
|---|---|---|---|
Revenue | 433.8m | 453.0m | 460.0m |
Revenue growth, % | 4% | 2% | |
Cost of goods sold | 93.0m | 96.6m | 100.6m |
Gross profit | 340.8m | 356.4m | 359.3m |
Gross profit Margin, % | 79% | 79% | 78% |
Sales and marketing expense | 198.4m | 205.5m | 223.7m |
R&D expense | 29.7m | 33.2m | 34.6m |
General and administrative expense | 74.4m | 84.5m | 85.6m |
Operating expense total | 302.5m | 323.3m | 343.9m |
EBIT | 40.8m | 30.1m | (18.8m) |
EBIT margin, % | 9% | 7% | (4%) |
Interest expense | 416.0k | 828.0k | 122.0k |
Pre tax profit | 36.4m | 22.9m | (27.0m) |
Income tax expense | 29.1m | 9.1m | 1.4m |
Net Income | 6.2m | 13.8m | (28.5m) |
EPS | 0.3 | 0.7 | (1.5) |
Quarterly
| USD | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 |
|---|---|---|---|---|---|---|---|---|---|
Revenue | 108.7m | 111.5m | 111.7m | 109.1m | 115.9m | 113.5m | 104.8m | 73.1m | 111.0m |
Cost of goods sold | 24.1m | 22.8m | 24.0m | 23.7m | 25.8m | 24.9m | 23.4m | 23.2m | 26.2m |
Gross profit | 84.6m | 88.7m | 87.7m | 85.4m | 90.0m | 88.6m | 81.4m | 50.0m | 84.7m |
Gross profit Margin, % | 78% | 80% | 78% | 78% | 78% | 78% | 78% | 68% | 76% |
Sales and marketing expense | 50.3m | 51.5m | 49.9m | 53.7m | 56.9m | 54.8m | 54.3m | 43.5m | 52.9m |
R&D expense | 6.9m | 7.9m | 9.6m | 9.2m | 9.0m | 8.0m | 10.0m | 8.8m | 10.0m |
General and administrative expense | 19.5m | 22.3m | 22.7m | 20.5m | 21.9m | 21.1m | 17.9m | 15.0m | 16.5m |
Operating expense total | 76.7m | 81.7m | 82.2m | 83.4m | 87.8m | 83.9m | 82.1m | 67.3m | 79.4m |
EBIT | 7.9m | 7.0m | 3.9m | (4.4m) | 451.0k | (18.9m) | 6.9m | (21.0m) | 4.2m |
EBIT margin, % | 7% | 6% | 3% | (4%) | 0% | (17%) | 7% | (29%) | 4% |
Interest expense | 183.0k | 251.0k | 181.0k | 257.0k | 457.0k | 186.0k | 423.0k | 901.0k | 731.0k |
Pre tax profit | 10.6m | 2.0m | (1.3m) | (5.1m) | 672.0k | (26.8m) | 5.6m | (16.8m) | 5.3m |
Income tax expense | 5.4m | 1.1m | (115.0k) | (6.0m) | 1.2m | 13.7m | (20.0m) | 1.6m | 607.0k |
Net Income | 5.2m | 925.0k | (1.2m) | 897.0k | (547.0k) | (40.5m) | 25.7m | (18.4m) | 4.7m |
EPS | 0.3 | 0.1 | (0.1) | 0.1 | 0.0 | (2.1) | 1.3 | (1.0) | 0.2 |
Orthofix Balance Sheet
Annual
| USD | FY, 2017 | FY, 2018 | FY, 2019 |
|---|---|---|---|
Cash | 81.2m | 69.6m | 69.7m |
Accounts Receivable | 63.4m | 77.7m | 86.8m |
Prepaid Expenses | 25.9m | 17.9m | 20.9m |
Inventories | 81.3m | 76.8m | 82.4m |
Current Assets | 251.8m | 244.6m | 260.6m |
PP&E | 45.1m | 42.8m | 62.7m |
Goodwill | 53.6m | 72.4m | 71.2m |
Total Assets | 405.4m | 466.6m | 495.6m |
Accounts Payable | 18.1m | 18.0m | 19.9m |
Short-term debt | 323.0k | ||
Current Liabilities | 79.4m | 85.9m | 84.9m |
Long-term debt | 20.6m | ||
Total Debt | 21.0m | ||
Total Liabilities | 108.7m | 131.2m | 168.0m |
Common Stock | 1.8m | 1.9m | 1.9m |
Additional Paid-in Capital | 220.6m | 243.2m | 271.0m |
Retained Earnings | 70.4m | 87.1m | 57.7m |
Total Equity | 296.6m | 335.4m | 327.6m |
Debt to Equity Ratio | 0.1 x | ||
Debt to Assets Ratio | 0 x | ||
Financial Leverage | 1.4 x | 1.4 x | 1.5 x |
Quarterly
Orthofix Cash Flow
Annual
| USD | FY, 2017 | FY, 2018 | FY, 2019 |
|---|---|---|---|
Net Income | 6.2m | 13.8m | (28.5m) |
Depreciation and Amortization | 20.1m | 18.7m | 24.7m |
Accounts Receivable | (6.6m) | (3.7m) | (11.0m) |
Inventories | (15.6m) | 9.7m | (5.7m) |
Accounts Payable | 2.3m | (170.0k) | 2.1m |
Cash From Operating Activities | 53.3m | 49.9m | 32.0m |
Purchases of PP&E | (14.7m) | (13.6m) | (19.0m) |
Cash From Investing Activities | (16.5m) | (61.0m) | (22.9m) |
Long-term Borrowings | (365.0k) | ||
Cash From Financing Activities | 3.5m | 3.0m | (10.7m) |
Net Change in Cash | 41.6m | (9.0m) | (1.8m) |
Interest Paid | 811.0k | ||
Income Taxes Paid | 3.3m |
Quarterly
| USD | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 |
|---|---|---|---|---|---|---|---|---|---|
Net Income | 5.2m | 6.2m | 4.9m | 897.0k | 350.0k | (40.1m) | 25.7m | 7.2m | 11.9m |
Depreciation and Amortization | 4.4m | 8.9m | 13.7m | 5.7m | 11.9m | 18.2m | 6.3m | 13.3m | 22.3m |
Accounts Receivable | (4.9m) | (363.0k) | (225.0k) | (2.0m) | (3.5m) | (3.3m) | 6.7m | 16.3m | 11.6m |
Inventories | 1.7m | 5.3m | 6.9m | (2.5m) | (2.4m) | (5.0m) | (848.0k) | 468.0k | 246.0k |
Accounts Payable | (4.5m) | (3.8m) | (2.8m) | 1.9m | 1.6m | 447.0k | 28.0k | (4.8m) | (3.1m) |
Cash From Operating Activities | (3.6m) | 13.0m | 28.8m | (1.0m) | 8.3m | 20.1m | 12.5m | 30.1m | 52.0m |
Purchases of PP&E | (2.8m) | (5.8m) | (9.6m) | (4.6m) | (9.6m) | (13.7m) | (4.3m) | (8.6m) | (11.6m) |
Cash From Investing Activities | (4.7m) | (51.5m) | (55.9m) | (11.3m) | (16.7m) | (21.3m) | (24.2m) | (28.6m) | (42.9m) |
Long-term Borrowings | (99.0k) | (188.0k) | (276.0k) | (92.0k) | (124.0k) | (100.2m) | |||
Cash From Financing Activities | 3.7m | 3.7m | 3.0m | (10.4m) | (11.6m) | (12.6m) | 315.0k | 101.9m | 583.0k |
Net Change in Cash | (4.1m) | (35.5m) | (24.9m) | (23.0m) | (20.0m) | (14.7m) | (12.1m) | 103.0m | 9.9m |
Orthofix Ratios
| USD | FY, 2017 |
|---|---|
Revenue/Employee | 505.6k |
Financial Leverage | 1.4 x |
